Document Detail

Statin therapy in lower limb peripheral arterial disease: Systematic review and meta-analysis.
MedLine Citation:
PMID:  25446168     Owner:  NLM     Status:  Publisher    
OBJECTIVE: To investigate and analyse the existing evidence supporting statin therapy in patients with lower limb atherosclerotic arterial disease.
METHODS: A systematic search of electronic information sources was undertaken to identify studies comparing cardiovascular outcomes in patients with lower limb peripheral arterial disease treated with a statin and those not receiving a statin. Estimates were combined applying fixed- or random-effects models.
RESULTS: Twelve observational cohort studies and two randomised trials reporting 19,368 patients were selected. Statin therapy was associated with reduced all-cause mortality (odds ratio 0.60, 95% confidence interval 0.46-0.78) and incidence of stroke (odds ratio 0.77, 95% confidence interval 0.67-0.89). A trend towards improved cardiovascular mortality (odds ratio 0.62, 95% confidence interval 0.35-1.11), myocardial infarction (odds ratio 0.62, 95% confidence interval 0.38-1.01), and the composite of death/myocardial infarction/stroke (odds ratio 0.91, 95% confidence interval 0.81-1.03), was identified. Meta-analyses of studies performing adjustments showed decreased all-cause mortality in statin users (hazard ratio 0.77, 95% confidence interval 0.68-0.86).
CONCLUSIONS: Evidence supporting statins' protective role in patients with lower limb peripheral arterial disease is insufficient. Statin therapy seems to be effective in reducing all-cause mortality and the incidence cerebrovascular events in patients diagnosed with peripheral arterial disease.
George A Antoniou; Robert K Fisher; George S Georgiadis; Stavros A Antoniou; Francesco Torella
Related Documents :
16980878 - The future of therapeutic myocardial angiogenesis.
15702618 - Elevated heart rate: a major risk factor for cardiovascular disease.
9857918 - Angiotensin ii type 1 receptor a1166c gene polymorphism. absence of an association with...
3799698 - Risk predictors, risk indicators, and benefit factors in hypertension.
21946818 - Coupled pacing controls rapid heart rates better than paired pacing during atrial fibri...
23775198 - Circulation editors' picks: most read articles in heart failure.
Publication Detail:
Type:  REVIEW     Date:  2014-10-18
Journal Detail:
Title:  Vascular pharmacology     Volume:  63     ISSN:  1879-3649     ISO Abbreviation:  Vascul. Pharmacol.     Publication Date:  2014 Nov 
Date Detail:
Created Date:  2014-12-2     Completed Date:  -     Revised Date:  2014-12-3    
Medline Journal Info:
Nlm Unique ID:  101130615     Medline TA:  Vascul Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  79-87     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Gallic acid inhibits vascular calcification through the blockade of BMP2-Smad1/5/8 signaling pathway...
Next Document:  Reprint of "An overview of freshwater snails in Asia with main focus on Vietnam"